Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression

Molecular Psychiatry

Volumn 7, Issue 1, 2002, Pages 44-55

  Miller, G M ^a   Madras, B K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ADHD; Cloning; Cocaine; HSV TK; Interaction; Luciferase; Promoter; SNP; SV40; VNTR

Indexed keywords

DOPAMINE TRANSPORTER; LUCIFERASE; CARRIER PROTEIN; HYBRID PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; RHESUS MONKEY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANTIA NIGRA; TANDEM REPEAT; UNTRANSLATED REGION; 3' UNTRANSLATED REGION; ALLELE; ANIMAL; BIOSYNTHESIS; CELL LINE; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MACACA; METABOLISM;

3' UNTRANSLATED REGIONS; ALLELES; ANIMALS; CELL LINE; CLONING, MOLECULAR; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; SUBSTANTIA NIGRA; TRANSFECTION;

EID: 85047685329     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000921     Document Type: Article

References (75)

1. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
2. Cloning and expression of a cocaine-sensitive rat dopamine transporter
3. Neurotransmitter transporters: Fruitful targets for CNS drug discovery
4. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease
5. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients
6. Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
7. Decreased dopamine transporters with age in healthy human subjects
8. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age
9. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum
10. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain
11. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo
12. Dopamine transporter density in patients with attention deficit hyperactivity disorder
13. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
14. Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
15. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
16. Striatal dopamine transporter density in major depression
17. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal
18. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration
19. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
20. A rapid and reversible change in dopamine transporters induced by methamphetamine
21. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
22. Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations
23. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)
24. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease
25. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
26. Population genetic study of the human dopamine transporter gene (DAT1)
27. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3)
28. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations
29. Association of attention-deficit disorder and the dopamine transporter gene
30. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
31. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
32. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
33. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response
34. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
35. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia
36. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium
37. DAT1 gene polymorphism in alcoholism: A family-based association study
38. Genotype influences in vivo dopamine transporter availability in human striatum
39. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene
40. Evidence suggesting the role of specific genetic factors in cigarette smoking
41. A genetic association for cigarette smoking behavior
42. Association of smoking and personality with a polymorphism of the dopamine transporter gene: Results from a community survey
43. Prediction of dopamine transporter binding availability by genotype: A preliminary report
44. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: Implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders
45. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism
46. Molecular characterization of the dopamine transporter
47. Biogenic amine transporters: Regulation in flux
48. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease
49. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease
50. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: No association found
51. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode
52. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia
53. Lack of association between dopamine transporter gene polymorphisms and delusional disorder
54. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse
55. Human dopamine transporter gene polymorphism (VNTR) and alcoholism
56. Lack of association between dopamine transporter (DAT1) and ADHD
57. Cytoplasmic regulation of mRNA function: The importance of the 3′ untranslated region
58. Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts
59. The human dopamine transporter gene: The 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample
60. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
61. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: Relevance to cocaine sensitivity
62. Cocaine and dopamine: Differential effects on dopamine transporter distribution
63. The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3′-untranslated region
64. Translational regulation of parathyroid hormone gene expression and RNA: Protein interactions
65. Human phosducin-like protein (hPhLP) messenger RNA stability is regulated by cis-acting instability elements present in the 3′-untranslated region
66. The 3′ UTR of human MnSOD mRNA hybridizes to a small cytoplasmic RNA and inhibits gene expression
67. Tenotomy decreases reporter protein synthesis via the 3′-untranslated region of the beta-myosin heavy chain mRNA
68. Technepine: A high-affinity 99m-technetium probe to label the dopamine transporter in brain by SPECT imaging
69. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease
70. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1
71. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: Multivariate regression analysis of 20 genes
72. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder
73. Site-directed mutagenesis of the -10 region of the lacUV5 promoter. Introduction of dA4.dT4 tract suppresses open complex formation
74. Genetic variation in the 3′ untranslated region of the neurofibromatosis 1 gene: Application to unequal allelic expression
75. Efficiency of different viral promoters in directing gene expression in mammalian cells: Effect of 3′-untranslated sequences